---
title: Does IPSS-R down staging before transplantation improve the prognosis of patients
  with Myelodysplastic neoplasms?
date: '2024-05-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38728380/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240511181524&v=2.18.0.post9+e462414
source: Blood
description: In MDS patients higher IPSS-R at transplant is associated with worse
  transplant outcome. Thus, it may seem beneficial to improve IPSS-R by therapeutic
  intervention prior to transplantation in order to "down-stage" the disease risk.
  However, there is no evidence to date to support this approach. A retrospective
  analysis of the EBMT transplant registry was performed to investigate the role of
  therapeutic interventions prior to transplantation with regard to changes in IPSS-R
  and ...
disable_comments: true
---
In MDS patients higher IPSS-R at transplant is associated with worse transplant outcome. Thus, it may seem beneficial to improve IPSS-R by therapeutic intervention prior to transplantation in order to "down-stage" the disease risk. However, there is no evidence to date to support this approach. A retrospective analysis of the EBMT transplant registry was performed to investigate the role of therapeutic interventions prior to transplantation with regard to changes in IPSS-R and ...